Cancer early detection and diagnosis can save lives

Once diagnose with cancer, you tend to think its the end of the world. Your dreams and future will drastically change, and suddenly everything is uncertain. Cancer will not only change your life but also your family and friends that will help and support you all the way.

Cancer is a class of diseases characterized by out-of-control cell growth. It is also caused by severe damaged genetic material that leads to random genetic instability.

Dr. Ioannis Papasotiriou is the medical geneticist and the current CEO and Medical Director of the Research Genetic Cancer Center, whose expertise is in molecular oncology in the entity of cancer stem cell. His interest in chemosensitivity testing and development of screening tests led his research activities to focus on cancer drug design and evaluation and in the development of innovative methods of cancer genes or molecular targeted therapies.

Cancer harms the body when altered cells divide uncontrollably to form lumps or masses of tissue called tumors except in the case of leukemia where cancer prohibits normal blood function by abnormal cell division in the bloodstream. Each malignancy behaves differently and the disease can evolve to survive the drugs designed to treat it.

“Cancer disease should be considered as a systematic disease from day one,” according to Dr. Ioannis Papasotiriou, CEO and Medical Director of Research Genetic Cancer Center (RGCC). Meaning cancer is affecting the entire body, rather than a single organ or body part.

Early detection and diagnosis can save lives.

Early detection of cancer greatly increases the chances for successful treatment. There are two major components of early detection of cancer: education to promote early diagnosis and screening.

Each person will have a unique, genetic response depending on their genetic fingerprint. That’s why RGCC open a new front in the war of cancer. Its approach is focused on early detection, personalized chemosensitivity testing, and accurate monitoring.

What is Research Genetic Cancer Center (RGCC)?

RGCC is a world-class laboratory who understands that each patient is unique. It specializes in medical genetics, especially cancer genetics, that allows delivering a customized approach to testing and treatment.

RGCC cancer tests can personalize individual cancer care by detecting the early signs of developing cancer. Monitor the existing cancers and subjecting or testing each patients cancers cells against a wide array of well-known cancer drugs and natural substances to identify the best treatment option.

The main goal of RGCC Genetic Cancer tests is to discover, analyze, and screen the cancer cells at every stage of the disease to give the patient an advantage against the fight against cancer.

With the information from the tests, patients and their doctors are better equipped in creating a precise, effective and sustainable health management plan. Meanwhile, health and wellness facilities focused on creating health can work with the patient and physician in developing a health plan that would keep the rest of the body strong and healthy, through diet and lifestyle modification, to help prevent the spread of cancer. The attending physician or oncologist can focus more on the cancer treatment and management plan.

The RGCC Genetic Cancer tests are made available and accessible by Global Medical Technologies (GMT). GMT has been at the forefront of making some of the most up-to-date and relevant medical technologies and diagnostics from developed countries accessible to Filipino medical practitioners and patients, and help them outsmart health issues.

The RGCC tests can be requested by your Physician. It is exclusively distributed in the Philippines by Global Medical Technologies, for more information, patients and health practitioners may visit www.gmtmanila.com.